FIGS News & Events

Figs is down -28.0%, or -$4.31 to $11.06.

Figs is down -25.8%, or -$3.97 to $11.40.

Sees 2026 adjusted EBITDA margin 13.0%-13.2%. The company said, "Our strong start to 2026 fuels our confidence and supports higher net revenues and adjusted EBITDA margin expectations for the rest of the year. We now expect top-line growth of 14% to 16%, including growth in the low 20% range in Q2, driven by strength across active customers, AOV, and frequency. Our improved bottom-line outlook reflects our top-line momentum and operational execution, enabling continued investments in growth while effectively managing higher freight surcharges. Finally, our balance sheet remains a source of strength, positioning us to continue driving shareholder returns."

Reports Q1 revenue $159.9M, consensus $153.14M. Reports active customers as of March 31 increased 12.2% year over year to 3.0M. Net revenues per active customer was $220, an increase of 5.8% year over year. The company said, "Our outperformance in the first quarter shows that our broad-based momentum from 2025 has continued into 2026. Our excellent top line growth was driven by both acceleration in our active customer base, which surpassed three million for the first time in our history, and strong repeat dynamics. We also paired our top line beat with upside to the bottom line, highlighting the structural advantage of our business model. We believe our product, brand, and community strategies, combined with the substantial long-term tailwinds in healthcare, position us for continued success going forward."